Organisation: Amryt

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Amryt Pharma gets US patent for headline drug
Amryt Pharma gets US patent for headline drug
Amryt Pharma has been granted a US patent for its lead drug to be used as a treatment in the lucrative orphan disease market.

Wed, 14 Sep, 2016

Amryt Pharma targets €1.3bn orphan disease market
Amryt Pharma targets €1.3bn orphan disease market

Dublin-listed drug firm Amryt Pharma is planning to widen the scope of its late-stage wound-healing drug this year, to target the $1.5bn (€1.3bn) orphan disease market.

Fri, 10 Jun, 2016

Fastnet Equity in €37m debut deal
Fastnet Equity in €37m debut deal

Dublin-based investment firm Fastnet Equity has reached conditional agreement to acquire drug firm Amryt Pharmaceuticals for £29.6m (€37.5m).

Fri, 01 Apr, 2016

Latest

Mick Clifford
Mick Clifford

News

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited